Plain-English translation of NCT07108907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study that collects data from patients undergoing a minimally invasive heart procedure called transcatheter edge-to-edge repair (M-TEER) to fix a leaky mitral valve. The procedure uses devices like the MitraClip or PASCAL to repair the valve without open-heart surgery. Researchers are tracking patient outcomes to better understand who benefits most from this treatment and how well it works over time.
A leaky mitral valve is increasingly common, especially in older adults, and this minimally invasive procedure offers an alternative for patients who cannot have traditional heart surgery. By collecting detailed information from all patients who receive this treatment, doctors hope to improve patient selection and understand which patients have the best results.
You likely qualify if…
You likely don't qualify if…
If you are selected for this study, you will receive the minimally invasive valve repair procedure as planned, and then researchers will collect information about your health outcomes, symptoms, and quality of life over time. This is primarily a data collection study, so your main participation involves allowing doctors to use your medical information and answering health questionnaires as part of the registry.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Netherlands
Enrollment target
~300 participants
Started
July 2025
Primary completion
January 2030
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Abby E Geerlings, MD
Abby Geerlings
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.